24 studies found for:    " January 18, 2012":" February 17, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" January 18, 2012":" February 17, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Medical Marijuana Use in HIV+ Patients Prospective Cohort Study
Conditions: HIV Positive;   Marijuana Smoking
Intervention:
2 Recruiting Medical Marijuana Use in HIV+ Patients: Probability Survey
Condition: HIV Positive
Intervention:
3 Completed Open-Label Pilot Study to Evaluate Switching From a Regimen Consisting of Raltegravir Plus Emtricitabine/Tenofovir DF Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Intervention: Drug: EVG/COBI/FTC/TDF
4 Completed
Has Results
Intervention to Retain HIV-positive Patients in Medical Care
Condition: Primary Care Appointment Keeping
Interventions: Behavioral: Enhanced contact plus behavioral skills;   Behavioral: Enhanced contact only;   Behavioral: Standard of Care
5 Unknown  Development of Method of Fructose Identification in Urine to Detect the Viral Infection
Condition: Human Immunodeficiency Virus
Intervention:
6 Completed Use of Incentives to Engage Drug Users in HIV Therapy
Condition: HIV Infection
Intervention: Other: monetary reinforcer
7 Active, not recruiting Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection
Conditions: HCV Coinfection;   HIV Infection
Intervention: Drug: Nitazoxanide
8 Recruiting Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1:FOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC (MARAVI-PEP)
Condition: HIV Infection
Interventions: Drug: Tenofovir, emtricitabine, maraviroc;   Drug: Tenofovir, emtricitabine, lopinavir/r
9 Unknown  Dolutegravir Expanded Access Study
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: dolutegravir
10 Not yet recruiting Gender-Specific Combination HIV Prevention for Youth in High Burden Settings (MP3-Youth)
Conditions: HIV;   Adolescent Behavior;   Gender
Interventions: Other: Male-Specific Intervention Package;   Other: Female-Specific Intervention Package;   Drug: Pre-Exposure Prophylaxis (Females);   Behavioral: Cash Transfer Cohort (Females)
11 Active, not recruiting Evaluation of the MBio Combined Syphilis/HIV Point-of-Care Diagnostic Test
Conditions: HIV;   Syphilis
Intervention: Device: MBIO POC combined HIV syphilis test ( SnapEsi)
12 Recruiting ACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot Study
Condition: HIV
Interventions: Drug: Lisinopril;   Drug: Placebo
13 Recruiting Vitamin D Supplementation in HIV Youth
Condition: HIV+
Intervention: Drug: Vitamin D3
14 Completed Early Access to TMC114/r and Other AVT for Treatment-naive or Early Treatment Experienced in HIV-1 Patients
Condition: HIV-1
Intervention: Drug: TMC114/ritonavir
15 Terminated Safety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following Potential Exposure to HIV
Condition: HIV
Interventions: Drug: 3 drug regimen: Tenofovir DF and Emtricitabine; Ritonavir-boosted Atazanavir;   Drug: Ritonavir, Atazanavir, Truvada
16 Recruiting Four-Arm Randomized Control Trial of Brief MI Versus Couples-Based HIV/STI Prevention in South Africa
Condition: HIV Prevention
Interventions: Other: Testing and Counseling;   Behavioral: Brief Motivational Interview (BMI);   Behavioral: Integrated Family and Cognitive Behavioral Therapy
17 Unknown  Tuberculosis Recurrence Upon Treatment With Highly Active Antiretroviral Therapy
Condition: Tuberculosis
Intervention:
18 Completed Safety and Metabolic Study of Highly Active Antiretroviral Therapy (HAART) in Malnourished Children With HIV
Conditions: Kwashiorkor;   Marasmus;   Severe Acute Malnutrition;   HIV
Intervention: Drug: zidovudine, lamivudine, nevirapine
19 Completed The Neurocognitive Sub-study of Encore1
Condition: HIV
Intervention: Drug: Efavirenz
20 Recruiting Effects of Losartan and Antiretroviral Regimen Containing Raltegravir in Fibrosis Inflammation Mediators, Cardiovascular Risk and Neurocognitive Disorders in HIV Infected Patients Previously Effectively Treated
Condition: HIV-1
Interventions: Drug: EFV/FTC/TDF + Losartan;   Drug: EFV/FTC/TDF;   Drug: FTC/TDF + MK-0518;   Drug: FTC/TDF+MK-0518+Losartan

   Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results    Last Page
Indicates status has not been verified in more than two years